Detalhe da pesquisa
1.
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.
Am J Hematol
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38884137
2.
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.
Am J Hematol
; 98(5): 703-711, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710399
3.
Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.
Am J Hematol
; 97(2): 174-184, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724251
4.
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Haematologica
; 106(3): 730-735, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107337
5.
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD).
Am J Hematol
; 96(12): 1639-1646, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34653287
6.
Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.
Pharmacoepidemiol Drug Saf
; 26(11): 1357-1366, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28809079
7.
Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
Proc Natl Acad Sci U S A
; 111(44): E4762-8, 2014 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341731
8.
Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.
PLoS Pathog
; 9(7): e1003484, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874201
9.
Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review.
Support Care Cancer
; 23(4): 993-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25256378
10.
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.
Cancer
; 120(8): 1194-202, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24474568
11.
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Lancet Haematol
; 10(8): e624-e632, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532416
12.
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Blood
; 115(15): 3008-16, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20023215
13.
Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.
Am J Hematol
; 87(3): 308-10, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22262486
14.
Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review.
Support Care Cancer
; 20(9): 2089-96, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160485
15.
Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma.
Clin Cancer Res
; 28(12): 2485-2487, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380669
16.
Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach.
J Bone Oncol
; 34: 100423, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378840
17.
A retrospective analysis of venous thromboembolism trends in chemotherapy-induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration.
EJHaem
; 1(1): 35-43, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847693
18.
A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.
J Thorac Oncol
; 15(2): 190-202, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629060
19.
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.
Br J Haematol
; 144(3): 409-15, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19016720
20.
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
Lancet
; 371(9610): 395-403, 2008 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-18242413